.png){kind=icon}
返回
Recent Progress in Glucose-Responsive Insulin
.png){kind=icon}
PRE
AI
DOI：10.2337/dbi23-0028.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Insulin replacement therapy is indispensable in the treatment of type 1 and advanced type 2 diabetes. However, insulin's clinical application is challenging due to its narrow therapeutic index. To mitigate acute and chronic risks of glucose excursions, glucose-responsive insulin (GRI) has long been pursued for clinical application. By integrating GRI with glucose-sensitive elements, GRI is capable of releasing or activating insulin in response to plasma or interstitial glucose levels without external monitoring, thereby improving glycemic control and reducing hypoglycemic risk. In this Perspective, we first introduce the history of GRI development and then review major glucose-responsive components that can be leveraged to control insulin delivery. Subsequently, we highlight the recent advances in GRI delivery carriers and insulin analogs. Finally, we provide a look to the future and the challenges of clinical application of GRI.
Keyword:
SENSITIVE VESICLES
BETA-CELLS
HYDROGELS
DELIVERY
HYPOXIA
COMPLEX
PATCHES
期刊
IF:
7.5
论文数:
2.6W
被引数:
4.6W
机构
引用论文
Glucose-responsive oral insulin delivery for postprandial glycemic regulation用于餐后血糖调节的葡萄糖响应性口服胰岛素递送
PREAI
分享收藏Microneedle-array patch with pH-sensitive formulation for glucose-responsive insulin delivery具有pH敏感配方的微针阵列贴片，用于葡萄糖响应性胰岛素递送
PREAI
分享收藏分享收藏Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs.png)
SCIENCE ADVANCES
OAAI
SCIENCE ADVANCESIF12.5
OAAI分享收藏Injectable nanosized formulation for glucose-responsive insulin delivery用于葡萄糖响应性胰岛素递送的可注射纳米制剂NANO TODAY
NANO TODAYIF10.9
PREAI
分享收藏
查看更多内容